Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Researchers have developed a vaccine that blocks the effects of the main cause of pain in osteoarthritis (OA) - nerve growth factor (NGF) - in mice.

Research Assistant in Immunology and Inflammation (185107)

With several clinical studies currently active in the lab you will be part of the team investigating the cellular and molecular response of patients to standard of care treatments and biologics for diseases including Rheumatoid Arthritis and Inflammatory Bowel Disease.

Meet the Kennedy team

  • Tonia Vincent
    Tonia Vincent

    Associate Director of the Kennedy Institute and the Kennedy Trust Maini Feldmann Professor of Translational Musculoskeletal Science

Read the paper

Active immunization targeting Nerve Growth Factor attenuates chronic pain behavior in murine osteoarthritis

Annals of Rheumatic Disease, 12 March 2019. doi: 10.1136/annrheumdis-2018-214489

Full paper

In collaboration with

Supported by

Versus Arthritis logo

Our research themes

Similar stories